AUG 19, 2026 · OBSERVATIONAL STUDY
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
ClinicalTrials.gov
This is an ongoing observational registry study with no results yet reported; it is designed to generate real-world safety and effectiveness data but carries no outcome evidence at this stage.
Reported
Planned enrollment1700
Primary outcome 1Incidence rate of new or worsening heart fa…
Primary outcome 2Change in resting LVOT gradient from baseli…